---
schema_version: "secwatch.filing_event.v1"
accession: "0000012208-24-000015"
form_type: "8-K"
ticker: "BIO"
cik: "0000012208"
company_name: "BIO-RAD LABORATORIES, INC."
filed_at: "2024-02-21T23:59:59+00:00"
generated_at: "2026-06-05T21:44:20.153107+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Bio-Rad discloses Sartorius AG FY 2023 results: revenue €3.4B, net profit €290M

## Summary
- Sartorius AG FY 2023 sales revenue €3,395.7M, gross profit €1,567.1M.
- EBIT €503.9M, net profit €290.0M for the year ended Dec 31, 2023.
- Operating cash flow €853.6M; investing cash flow -€2,823.3M; financing cash flow €2,165.7M.
- Total assets €9,755.4M, equity €2,757.4M as of Dec 31, 2023.

## SEC filing metadata
- accession: 0000012208-24-000015
- form_type: 8-K
- ticker: BIO
- cik: 0000012208
- company_name: BIO-RAD LABORATORIES, INC.
- filed_at: 2024-02-21T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 7.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/12208/000001220824000015/0000012208-24-000015-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/12208/000001220824000015/bio-20240221.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000012208-24-000015
- JSON: https://secwatch.observer/filing/0000012208-24-000015.json
- Plain text: https://secwatch.observer/filing/0000012208-24-000015.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.